Archer-Daniels-Midland Co Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $25B+2.6% YoYTTM through 30 Jun 2026
Net Income $1.8B-1.7% YoYTTM through 30 Jun 2026
Free Cash Flow $1.7BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 22.6% |
| EBITDA Margin | 13.1% |
| Operating Margin | 8.4% |
| Net Margin | 7.1% |
Returns
7.5%ROE
3.3%ROA
5.9%ROIC
Balance Sheet Health
Debt / Equity0.32x
Current Ratio1.39x
Net Debt$6.5B
Cash & Equivalents$1.1B
Quality Metrics
Altman Z-Score2.16
Piotroski F-Score7 / 9
FCF Margin6.7%
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $80.3B
Diluted EPS$3.66TTMFY2025: $2.23
Dividend
$1.04Per share, FY20261.26%Yield-6.8%5-yr growth
Capital Allocation
R&D Spend$246M
Capex Intensity4.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Ag Services and Oilseeds | View detailsThe company expects year-over-year segment operating profit growth for AS&O in 2026, with improvement in global trade flows and a range of potential crush margins outcomes. | ||
| Carbohydrate Solutions | View detailsThe company expects segment operating profit for Carbohydrate Solutions to remain relatively flat in 2026, with lower starches and sweeteners volumes and pricing offset by higher ethanol margins. | ||
| Nutrition | View detailsNutrition is expected to continue its trajectory of stronger organic growth and execution in 2026. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.